{"code":"P04.0","type":"code","title":"Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery","codeAlso":[],"includes":["nonteratogenic effects of substances transmitted via placenta"],"modern_v":"official26","codeFirst":["any current condition in newborn, if applicable"],"excludes1":[],"excludes2":["newborn affected by other maternal medication (P04.1-)","congenital malformations (Q00-Q99)","encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-)","neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4)","newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-)"],"isBillable":true,"fyEffectivity":{"fy2026":true,"fy2027":true,"billableFy2026":true,"billableFy2027":true},"sibling_codes":["P04","P04.1","P04.11","P04.12","P04.13","P04.14","P04.15","P04.16","P04.17","P04.18","P04.19","P04.1A","P04.2","P04.3","P04.4","P04.40","P04.41","P04.42","P04.49","P04.5","P04.6","P04.8","P04.81","P04.89","P04.9"],"inclusionTerms":["Newborn affected by reactions and intoxications from maternal opiates and tranquilizers administered for procedures during pregnancy or labor and delivery"],"sibling_titles":{"code":"P04.9","title":"Newborn affected by maternal noxious substance, unspecified","isBillable":true},"useAdditionalCode":[],"clinicalDefinition":"Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery is a billable ICD-10-CM diagnosis code (P04.0). Includes: nonteratogenic effects of substances transmitted via placenta. Inclusion terms: Newborn affected by reactions and intoxications from maternal opiates and tranquilizers administered for procedures during pregnancy or labor and delivery. Excludes2 (not included here): newborn affected by other maternal medication (P04.","officialDefinition":"Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and delivery is a billable ICD-10-CM diagnosis code (P04.0). Includes: nonteratogenic effects of substances transmitted via placenta. Inclusion terms: Newborn affected by reactions and intoxications from maternal opiates and tranquilizers administered for procedures during pregnancy or labor and delivery. Excludes2 (not included here): newborn affected by other maternal medication (P04.1-); congenital malformations (Q00-Q99); encounter for observation of newborn for suspected diseases and conditions ruled out (Z05.-); neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (P58.4); newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (Z77.-). Code first: any current condition in newborn, if applicable.","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":"","hcc":{"mapped":true,"model":"CMS-HCC V28","paymentYear":"2026","categories":[{"hcc":"137","label":"Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications","family":"SUD","suppresses":[{"hcc":"138","label":"Drug Use Disorder, Mild, Uncomplicated, Except Cannabis"},{"hcc":"139","label":"Alcohol Use Disorder, Moderate/Severe, or Alcohol Use with Specified Non-Psychotic Complications"}]}],"otherModels":[]}}